These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 16467198)

  • 1. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
    Betts MR; Nason MC; West SM; De Rosa SC; Migueles SA; Abraham J; Lederman MM; Benito JM; Goepfert PA; Connors M; Roederer M; Koup RA
    Blood; 2006 Jun; 107(12):4781-9. PubMed ID: 16467198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
    Hersperger AR; Pereyra F; Nason M; Demers K; Sheth P; Shin LY; Kovacs CM; Rodriguez B; Sieg SF; Teixeira-Johnson L; Gudonis D; Goepfert PA; Lederman MM; Frank I; Makedonas G; Kaul R; Walker BD; Betts MR
    PLoS Pathog; 2010 May; 6(5):e1000917. PubMed ID: 20523897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.
    Figueiredo S; Charmeteau B; Surenaud M; Salmon D; Launay O; Guillet JG; Hosmalin A; Gahery H
    Vaccine; 2014 Jan; 32(4):492-501. PubMed ID: 24291199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.
    Ndhlovu ZM; Stampouloglou E; Cesa K; Mavrothalassitis O; Alvino DM; Li JZ; Wilton S; Karel D; Piechocka-Trocha A; Chen H; Pereyra F; Walker BD
    J Virol; 2015 Nov; 89(21):10735-47. PubMed ID: 26269189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
    Horton H; Frank I; Baydo R; Jalbert E; Penn J; Wilson S; McNevin JP; McSweyn MD; Lee D; Huang Y; De Rosa SC; McElrath MJ
    J Immunol; 2006 Nov; 177(10):7406-15. PubMed ID: 17082660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
    Imami N; Pires A; Hardy G; Wilson J; Gazzard B; Gotch F
    J Virol; 2002 Sep; 76(18):9011-23. PubMed ID: 12186885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.
    Perdomo-Celis F; Velilla PA; Taborda NA; Rugeles MT
    PLoS One; 2019; 14(1):e0210540. PubMed ID: 30625227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity.
    Propato A; Schiaffella E; Vicenzi E; Francavilla V; Baloni L; Paroli M; Finocchi L; Tanigaki N; Ghezzi S; Ferrara R; Chesnut R; Livingston B; Sette A; Paganelli R; Aiuti F; Poli G; Barnaba V
    Hum Immunol; 2001 Jun; 62(6):561-76. PubMed ID: 11390031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
    López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
    Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Proliferation Capacity of Gag-C-Specific Naive and Memory CD4+ and CD8+ T Lymphocytes in Rapid, Viremic Slow, and Slow Progressors During Human Immunodeficiency Virus Infection.
    Negi N; Mojumdar K; Singh R; Sharma A; Das BK; Sreenivas V; Vajpayee M
    Viral Immunol; 2018 Sep; 31(7):513-524. PubMed ID: 30156469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and function of HIV-specific CD8(+) T cells.
    Migueles SA; Connors M
    Immunol Lett; 2001 Nov; 79(1-2):141-50. PubMed ID: 11595301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
    Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
    Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
    Kostense S; Ogg GS; Manting EH; Gillespie G; Joling J; Vandenberghe K; Veenhof EZ; van Baarle D; Jurriaans S; Klein MR; Miedema F
    Eur J Immunol; 2001 Mar; 31(3):677-86. PubMed ID: 11241270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control.
    Viganò S; Negrón JJ; Tse S; Chowdhury FZ; Lichterfeld M; Yu XG
    AIDS; 2017 Jan; 31(2):207-212. PubMed ID: 27835619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.